{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T06:47:38Z","timestamp":1774939658542,"version":"3.50.1"},"reference-count":143,"publisher":"Springer Science and Business Media LLC","issue":"S17","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T00:00:00Z","timestamp":1728432000000},"content-version":"vor","delay-in-days":8,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Johannes Kepler University Linz"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Wien Klin Wochenschr"],"published-print":{"date-parts":[[2024,10]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:p>Die Sarkoidose ist in vielen F\u00e4llen eine Multisystemerkrankung, die eine interdisziplin\u00e4re medizinische Zusammenarbeit in Diagnostik, Therapie und in der medizinischen Betreuung im Verlauf erfordert. Aufgrund des oft chronischen Verlaufes ist es besonders wichtig, Patientinnen und Patienten mit ihren Priorit\u00e4ten und W\u00fcnschen fr\u00fchzeitig und umfassend in die medizinische Betreuung einzubinden und, wenn m\u00f6glich, ein \u201eshared decision making\u201c zu etablieren. Beim Verfassen dieses gemeinsamen Positionspapieres war es der Expertengruppe f\u00fcr interstitielle Lungenerkrankungen und \u201eorphan diseases\u201c der \u00d6sterreichischen Gesellschaft f\u00fcr Pneumologie sowie der Arbeitsgruppe Rheuma und Lunge der \u00d6sterreichischen Gesellschaft f\u00fcr Rheumatologie und Rehabilitation ein besonderes Anliegen, sowohl PatientInnenvertreter als auch ExpertInnen f\u00fcr seltenere Organmanifestationen der Sarkoidose einzubeziehen. Dieses Positionspapier soll nicht nur ein Spiegel der aktuellen klinischen und wissenschaftlichen Praxis sein, sondern auch die nationale Expertise b\u00fcndeln und durch Vernetzung und Austausch ein erster Schritt zu einer St\u00e4rkung der Betreuungsstruktur von PatientInnen mit Sarkoidose sein.<\/jats:p>","DOI":"10.1007\/s00508-024-02444-z","type":"journal-article","created":{"date-parts":[[2024,10,9]],"date-time":"2024-10-09T09:01:47Z","timestamp":1728464507000},"page":"669-687","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Positionspapier der \u00d6GR und \u00d6GP zur Diagnose und Therapie der Sarkoidose 2024","Position paper of the Austrian Society for Rheumatology and the Austrian Society for Pneumology on the diagnosis and treatment of sarcoidosis 2024"],"prefix":"10.1007","volume":"136","author":[{"given":"Georg","family":"Sterniste","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Klaus","family":"Hackner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florentine","family":"Moazedi-F\u00fcrst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Grasl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Idzko","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guangyu","family":"Shao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudia","family":"Guttmann-Ducke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emina","family":"Talaki\u0107","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helmut","family":"Prosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sylvia","family":"Lohfink-Schumm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Gabriel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clarice","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johann","family":"Hochreiter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brigitte","family":"Bucher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara C","family":"B\u00f6ckle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans Peter","family":"Kiener","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christina","family":"Duftner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kastriot","family":"Kastrati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Rath","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marion","family":"Funk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Judith","family":"L\u00f6ffler-Ragg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Steinmaurer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabor","family":"Kovacs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas","family":"Verheyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Holger","family":"Flick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlies","family":"Antlanger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Traxler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Tatscher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ralf Harun","family":"Zwick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Lang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2024,10,9]]},"reference":[{"key":"2444_CR1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00991-2017","author":"JC Schupp","year":"2018","unstructured":"Schupp\u00a0JC, Freitag-Wolf\u00a0S, Bargagli\u00a0E, et\u00a0al. Phenotypes of organ involvement in sarcoidosis. Eur Respir\u00a0J. 2018; https:\/\/doi.org\/10.1183\/13993003.00991-2017.","journal-title":"Eur Respir J"},{"issue":"2","key":"2444_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.mayocp.2015.10.024","volume":"91","author":"P Ungprasert","year":"2016","unstructured":"Ungprasert\u00a0P, Carmona\u00a0EM, Utz\u00a0JP, Ryu\u00a0JH, Crowson\u00a0CS, Matteson\u00a0EL. Epidemiology of sarcoidosis 1946\u20132013: a\u00a0population-based study. Mayo Clin Proc. 2016;91(2):183\u20138. https:\/\/doi.org\/10.1016\/j.mayocp.2015.10.024.","journal-title":"Mayo Clin Proc"},{"issue":"1","key":"2444_CR3","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41572-019-0096-x","volume":"5","author":"J Grunewald","year":"2019","unstructured":"Grunewald\u00a0J, Grutters\u00a0JC, Arkema\u00a0EV, Saketkoo\u00a0LA, Moller\u00a0DR, M\u00fcller-Quernheim\u00a0J. Sarcoidosis. Nat Rev Dis Primers. 2019;5(1):45. https:\/\/doi.org\/10.1038\/s41572-019-0096-x.","journal-title":"Nat. Rev. Dis. Primers"},{"issue":"11","key":"2444_CR4","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1056\/NEJMra2101555","volume":"385","author":"M Drent","year":"2021","unstructured":"Drent\u00a0M, Crouser\u00a0ED, Grunewald\u00a0J. Challenges of sarcoidosis and its management. N\u00a0Engl J Med. 2021;385(11):1018\u201332. https:\/\/doi.org\/10.1056\/NEJMra2101555.","journal-title":"N Engl J Med"},{"issue":"5","key":"2444_CR5","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1097\/MCP.0000000000000715","volume":"26","author":"EV Arkema","year":"2020","unstructured":"Arkema\u00a0EV, Cozier\u00a0YC. Sarcoidosis epidemiology: recent estimates of incidence, prevalence and risk factors. Curr Opin Pulm Med. 2020;26(5):527\u201334. https:\/\/doi.org\/10.1097\/MCP.0000000000000715.","journal-title":"Curr Opin Pulm Med"},{"issue":"33","key":"2444_CR6","doi-asserted-by":"publisher","first-page":"565","DOI":"10.3238\/arztebl.2016.0565","volume":"113","author":"A Prasse","year":"2016","unstructured":"Prasse\u00a0A. The diagnosis, differential diagnosis, and treatment of sarcoidosis. Dtsch Arztebl Int. 2016;113(33):565\u201374. https:\/\/doi.org\/10.3238\/arztebl.2016.0565.","journal-title":"Dtsch Arztebl Int"},{"issue":"8","key":"2444_CR7","doi-asserted-by":"publisher","first-page":"1244","DOI":"10.1513\/AnnalsATS.201511-760OC","volume":"13","author":"RP Baughman","year":"2016","unstructured":"Baughman\u00a0RP, Field\u00a0S, Costabel\u00a0U, et\u00a0al. Sarcoidosis in america. Analysis based on health care use. Ann Am Thorac Soc. 2016;13(8):1244\u201352. https:\/\/doi.org\/10.1513\/AnnalsATS.201511-760OC.","journal-title":"Ann Am Thorac Soc"},{"issue":"8","key":"2444_CR8","doi-asserted-by":"publisher","first-page":"e26","DOI":"10.1164\/rccm.202002-0251ST","volume":"201","author":"ED Crouser","year":"2020","unstructured":"Crouser\u00a0ED, Maier\u00a0LA, Wilson\u00a0KC, et\u00a0al. Diagnosis and detection of sarcoidosis. An official American thoracic society clinical practice guideline. Am J Respir Crit Care Med. 2020;201(8):e26\u2013e51. https:\/\/doi.org\/10.1164\/rccm.202002-0251ST.","journal-title":"Am J Respir Crit Care Med"},{"key":"2444_CR9","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1146\/annurev-immunol-032712-100022","volume":"36","author":"AJ Pag\u00e1n","year":"2018","unstructured":"Pag\u00e1n\u00a0AJ, Ramakrishnan\u00a0L. The formation and function of granulomas. Annu Rev Immunol. 2018;36:639\u201365. https:\/\/doi.org\/10.1146\/annurev-immunol-032712-100022.","journal-title":"Annu Rev Immunol"},{"issue":"9","key":"2444_CR10","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1164\/rccm.201202-0320ST","volume":"185","author":"KC Meyer","year":"2012","unstructured":"Meyer\u00a0KC, Raghu\u00a0G, Baughman\u00a0RP, et\u00a0al. An official American thoracic society clinical practice guideline: the clinical utility of bronchoalveolar lavage cellular analysis in interstitial lung disease. Am J Respir Crit Care Med. 2012;185(9):1004\u201314. https:\/\/doi.org\/10.1164\/rccm.201202-0320ST.","journal-title":"Am J Respir Crit Care Med"},{"key":"2444_CR11","doi-asserted-by":"publisher","first-page":"1443","DOI":"10.3389\/fimmu.2020.01443","volume":"11","author":"R Kraaijvanger","year":"2020","unstructured":"Kraaijvanger\u00a0R, Janssen Bon\u00e1s\u00a0M, Vorselaars\u00a0ADM, Veltkamp\u00a0M. Biomarkers in the diagnosis and prognosis of sarcoidosis: current use and future prospects. Front Immunol. 2020;11:1443. https:\/\/doi.org\/10.3389\/fimmu.2020.01443.","journal-title":"Front Immunol"},{"issue":"9923","key":"2444_CR12","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/S0140-6736(13)60680-7","volume":"383","author":"D Valeyre","year":"2014","unstructured":"Valeyre\u00a0D, Prasse\u00a0A, Nunes\u00a0H, Uzunhan\u00a0Y, Brillet\u00a0P\u2011Y, M\u00fcller-Quernheim\u00a0J. Sarcoidosis. Lancet. 2014;383(9923):1155\u201367. https:\/\/doi.org\/10.1016\/S0140-6736(13)60680-7.","journal-title":"Lancet"},{"issue":"1","key":"2444_CR13","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1136\/thoraxjnl-2019-214348","volume":"76","author":"M Thillai","year":"2021","unstructured":"Thillai\u00a0M, Atkins\u00a0CP, Crawshaw\u00a0A, et\u00a0al. BTS clinical statement on pulmonary sarcoidosis. Thorax. 2021;76(1):4\u201320. https:\/\/doi.org\/10.1136\/thoraxjnl-2019-214348.","journal-title":"Thorax"},{"issue":"2","key":"2444_CR14","first-page":"113","volume":"30","author":"RP Baughman","year":"2013","unstructured":"Baughman\u00a0RP, Janovcik\u00a0J, Ray\u00a0M, Sweiss\u00a0N, Lower\u00a0EE. Calcium and vitamin\u00a0D metabolism in sarcoidosis. Sarcoidosis. 2013;30(2):113\u201320.","journal-title":"Sarcoidosis"},{"issue":"5261","key":"2444_CR15","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1136\/bmj.2.5261.1165","volume":"2","author":"JG Scadding","year":"1961","unstructured":"Scadding\u00a0JG. Prognosis of intrathoracic sarcoidosis in England. A\u00a0review of 136 cases after five years\u2019 observation. Br Med\u00a0J. 1961;2(5261):1165\u201372. https:\/\/doi.org\/10.1136\/bmj.2.5261.1165.","journal-title":"Br Med J"},{"key":"2444_CR16","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0085-2023","author":"D Bandyopadhyay","year":"2023","unstructured":"Bandyopadhyay\u00a0D, Mirsaeidi\u00a0MS. Sarcoidosis-associated pulmonary fibrosis: joining the dots. Eur Respir Rev. 2023; https:\/\/doi.org\/10.1183\/16000617.0085-2023.","journal-title":"Eur Respir Rev"},{"key":"2444_CR17","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-2600(23)00267-9","author":"SR Desai","year":"2023","unstructured":"Desai\u00a0SR, Sivarasan\u00a0N, Johannson\u00a0KA, et\u00a0al. High-resolution CT phenotypes in pulmonary sarcoidosis: a\u00a0multinational Delphi consensus study. Lancet Respir Med. 2023; https:\/\/doi.org\/10.1016\/S2213-2600(23)00267-9.","journal-title":"Lancet Respir Med"},{"issue":"6","key":"2444_CR18","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/j.amjmed.2023.02.014","volume":"136","author":"MA Judson","year":"2023","unstructured":"Judson\u00a0MA. The management of sarcoidosis in the 2020s by the primary care physician. Am J Med. 2023;136(6):534\u201344. https:\/\/doi.org\/10.1016\/j.amjmed.2023.02.014.","journal-title":"Am J Med"},{"key":"2444_CR19","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9030890","author":"RGM Keijsers","year":"2020","unstructured":"Keijsers\u00a0RGM, Grutters\u00a0JC. In which patients with sarcoidosis is FDG PET\/CT indicated? J\u00a0Clin Med. 2020; https:\/\/doi.org\/10.3390\/jcm9030890.","journal-title":"J Clin Med"},{"issue":"5","key":"2444_CR20","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1016\/j.acra.2014.01.008","volume":"21","author":"G Treglia","year":"2014","unstructured":"Treglia\u00a0G, Annunziata\u00a0S, Sobic-Saranovic\u00a0D, Bertagna\u00a0F, Caldarella\u00a0C, Giovanella\u00a0L. The role of 18F-FDG-PET and PET\/CT in patients with sarcoidosis: an updated evidence-based review. Acad Radiol. 2014;21(5):675\u201384. https:\/\/doi.org\/10.1016\/j.acra.2014.01.008.","journal-title":"Acad Radiol"},{"issue":"3","key":"2444_CR21","doi-asserted-by":"publisher","first-page":"e000867","DOI":"10.1161\/CIRCIMAGING.113.000867","volume":"9","author":"R Blankstein","year":"2016","unstructured":"Blankstein\u00a0R, Waller\u00a0AH. Evaluation of known or suspected cardiac sarcoidosis. Circ Cardiovasc Imaging. 2016;9(3):e867. https:\/\/doi.org\/10.1161\/CIRCIMAGING.113.000867.","journal-title":"Circ Cardiovasc Imaging"},{"key":"2444_CR22","doi-asserted-by":"publisher","first-page":"1340","DOI":"10.3389\/fimmu.2020.01340","volume":"11","author":"MA Judson","year":"2020","unstructured":"Judson\u00a0MA. Environmental risk factors for sarcoidosis. Front Immunol. 2020;11:1340. https:\/\/doi.org\/10.3389\/fimmu.2020.01340.","journal-title":"Front Immunol"},{"key":"2444_CR23","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00385-2018","author":"M Rossides","year":"2018","unstructured":"Rossides\u00a0M, Grunewald\u00a0J, Eklund\u00a0A, et\u00a0al. Familial aggregation and heritability of sarcoidosis: a\u00a0Swedish nested case-control study. Eur Respir\u00a0J. 2018; https:\/\/doi.org\/10.1183\/13993003.00385-2018.","journal-title":"Eur Respir J"},{"issue":"11","key":"2444_CR24","doi-asserted-by":"publisher","first-page":"2085","DOI":"10.1164\/ajrccm.164.11.2106001","volume":"164","author":"BA Rybicki","year":"2001","unstructured":"Rybicki\u00a0BA, Iannuzzi\u00a0MC, Frederick\u00a0MM, et\u00a0al. Familial aggregation of sarcoidosis. A\u00a0case-control etiologic study of sarcoidosis (ACCESS). Am J Respir Crit Care Med. 2001;164(11):2085\u201391. https:\/\/doi.org\/10.1164\/ajrccm.164.11.2106001.","journal-title":"Am J Respir Crit Care Med"},{"issue":"3","key":"2444_CR25","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1038\/ni.3655","volume":"18","author":"M Linke","year":"2017","unstructured":"Linke\u00a0M, Pham\u00a0HTT, Katholnig\u00a0K, et\u00a0al. Chronic signaling via the metabolic checkpoint kinase mTORC1 induces macrophage granuloma formation and marks sarcoidosis progression. Nat Immunol. 2017;18(3):293\u2013302. https:\/\/doi.org\/10.1038\/ni.3655.","journal-title":"Nat Immunol"},{"issue":"4","key":"2444_CR26","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.it.2020.01.007","volume":"41","author":"Y Pacheco","year":"2020","unstructured":"Pacheco\u00a0Y, Lim\u00a0CX, Weichhart\u00a0T, Valeyre\u00a0D, Bentaher\u00a0A, Calender\u00a0A. Sarcoidosis and the mTOR, Rac1, and autophagy triad. Trends Immunol. 2020;41(4):286\u201399. https:\/\/doi.org\/10.1016\/j.it.2020.01.007.","journal-title":"Trends Immunol"},{"key":"2444_CR27","doi-asserted-by":"publisher","first-page":"106294","DOI":"10.1016\/j.rmed.2020.106294","volume":"177","author":"A Pizzini","year":"2021","unstructured":"Pizzini\u00a0A, Bacher\u00a0H, Aichner\u00a0M, et\u00a0al. High expression of mTOR signaling in granulomatous lesions is not predictive for the clinical course of sarcoidosis. Respir Med. 2021;177:106294. https:\/\/doi.org\/10.1016\/j.rmed.2020.106294.","journal-title":"Respir Med"},{"issue":"19","key":"2444_CR28","doi-asserted-by":"publisher","first-page":"e030478","DOI":"10.1161\/JAHA.123.030478","volume":"12","author":"C Bueno-Beti","year":"2023","unstructured":"Bueno-Beti\u00a0C, Lim\u00a0CX, Protonotarios\u00a0A, et\u00a0al. An mTORC1-dependent mouse model for cardiac sarcoidosis. J\u00a0Am Heart Assoc. 2023;12(19):e30478. https:\/\/doi.org\/10.1161\/JAHA.123.030478.","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"2444_CR29","doi-asserted-by":"publisher","first-page":"280","DOI":"10.36141\/svdld.v34i4.6957","volume":"34","author":"RP Baughman","year":"2017","unstructured":"Baughman\u00a0RP, Judson\u00a0MA, Wells\u00a0A. The indications for the treatment of sarcoidosis: Wells\u00a0Law. Sarcoidosis. 2017;34(4):280\u20132. https:\/\/doi.org\/10.36141\/svdld.v34i4.6957.","journal-title":"Sarcoidosis"},{"issue":"3","key":"2444_CR30","first-page":"275","volume":"33","author":"X Hu","year":"2016","unstructured":"Hu\u00a0X, Carmona\u00a0EM, Yi\u00a0ES, Pellikka\u00a0PA, Ryu\u00a0J. Causes of death in patients with chronic sarcoidosis. Sarcoidosis. 2016;33(3):275\u201380.","journal-title":"Sarcoidosis"},{"issue":"5","key":"2444_CR31","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1007\/s00408-018-0144-4","volume":"196","author":"CC Moor","year":"2018","unstructured":"Moor\u00a0CC, van Manen\u00a0MJG, van Hagen\u00a0PM, et\u00a0al. Needs, perceptions and education in sarcoidosis: a\u00a0live interactive survey of patients and partners. Lung. 2018;196(5):569\u201375. https:\/\/doi.org\/10.1007\/s00408-018-0144-4.","journal-title":"Lung"},{"key":"2444_CR32","doi-asserted-by":"publisher","DOI":"10.1183\/23120541.00141-2018","author":"RP Baughman","year":"2018","unstructured":"Baughman\u00a0RP, Barriuso\u00a0R, Beyer\u00a0K, et\u00a0al. Sarcoidosis: patient treatment priorities. ERJ Open Res. 2018; https:\/\/doi.org\/10.1183\/23120541.00141-2018.","journal-title":"ERJ Open Res"},{"issue":"1","key":"2444_CR33","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1136\/thoraxjnl-2012-201962","volume":"68","author":"AS Patel","year":"2013","unstructured":"Patel\u00a0AS, Siegert\u00a0RJ, Creamer\u00a0D, et\u00a0al. The development and validation of the King\u2019s sarcoidosis questionnaire for the assessment of health status. Thorax. 2013;68(1):57\u201365. https:\/\/doi.org\/10.1136\/thoraxjnl-2012-201962.","journal-title":"Thorax"},{"issue":"8","key":"2444_CR34","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/S2213-2600(21)00311-8","volume":"9","author":"M Drent","year":"2021","unstructured":"Drent\u00a0M, Costabel\u00a0U, Crouser\u00a0ED, Grunewald\u00a0J, Bonella\u00a0F. Misconceptions regarding symptoms of sarcoidosis. Lancet Respir Med. 2021;9(8):816\u20138. https:\/\/doi.org\/10.1016\/S2213-2600(21)00311-8.","journal-title":"Lancet Respir Med"},{"issue":"8","key":"2444_CR35","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1055\/s-0042-100554","volume":"70","author":"A Bosse-Henck","year":"2016","unstructured":"Bosse-Henck\u00a0A, Wirtz\u00a0H, Hinz\u00a0A. Organ manifestation and subjective sleep quality in sarcoidosis. Pneumologie. 2016;70(8):522\u20139. https:\/\/doi.org\/10.1055\/s-0042-100554.","journal-title":"Pneumologie"},{"key":"2444_CR36","doi-asserted-by":"publisher","first-page":"S24","DOI":"10.1016\/j.rmed.2017.11.008","volume":"138","author":"C Hendriks","year":"2018","unstructured":"Hendriks\u00a0C, Drent\u00a0M, De Kleijn\u00a0W, Elfferich\u00a0M, Wijnen\u00a0P, De Vries\u00a0J. Everyday cognitive failure and depressive symptoms predict fatigue in sarcoidosis: a\u00a0prospective follow-up study. Respir Med. 2018;138:S24\u2013S30. https:\/\/doi.org\/10.1016\/j.rmed.2017.11.008.","journal-title":"Respir Med"},{"key":"2444_CR37","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9020390","author":"CC Moor","year":"2020","unstructured":"Moor\u00a0CC, Kahlmann\u00a0V, Culver\u00a0DA, Wijsenbeek\u00a0MS. Comprehensive care for patients with sarcoidosis. J\u00a0Clin Med. 2020; https:\/\/doi.org\/10.3390\/jcm9020390.","journal-title":"J Clin Med"},{"key":"2444_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/diagnostics11061089","author":"LA Saketkoo","year":"2021","unstructured":"Saketkoo\u00a0LA, Russell\u00a0A\u2011M, Jensen\u00a0K, et\u00a0al. Health-related quality of life (HRQoL) in sarcoidosis: diagnosis, management, and health outcomes. Diagnostics. 2021; https:\/\/doi.org\/10.3390\/diagnostics11061089.","journal-title":"Diagnostics"},{"issue":"1","key":"2444_CR39","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/j.chest.2017.07.008","volume":"153","author":"G Kirkil","year":"2018","unstructured":"Kirkil\u00a0G, Lower\u00a0EE, Baughman\u00a0RP. Predictors of mortality in pulmonary sarcoidosis. Chest. 2018;153(1):105\u201313. https:\/\/doi.org\/10.1016\/j.chest.2017.07.008.","journal-title":"Chest"},{"key":"2444_CR40","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.04079-2020","author":"RP Baughman","year":"2021","unstructured":"Baughman\u00a0RP, Valeyre\u00a0D, Korsten\u00a0P, et\u00a0al. ERS clinical practice guidelines on treatment of sarcoidosis. Eur Respir\u00a0J. 2021; https:\/\/doi.org\/10.1183\/13993003.04079-2020.","journal-title":"Eur Respir J"},{"issue":"11","key":"2444_CR41","doi-asserted-by":"publisher","first-page":"1524","DOI":"10.1164\/rccm.201010-1679OC","volume":"183","author":"JJ Swigris","year":"2011","unstructured":"Swigris\u00a0JJ, Olson\u00a0AL, Huie\u00a0TJ, et\u00a0al. Sarcoidosis-related mortality in the United States from 1988 to 2007. Am J Respir Crit Care Med. 2011;183(11):1524\u201330. https:\/\/doi.org\/10.1164\/rccm.201010-1679OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"16","key":"2444_CR42","doi-asserted-by":"publisher","first-page":"1878","DOI":"10.1016\/j.jacc.2020.08.042","volume":"76","author":"MG Trivieri","year":"2020","unstructured":"Trivieri\u00a0MG, Spagnolo\u00a0P, Birnie\u00a0D, et\u00a0al. Challenges in cardiac and pulmonary sarcoidosis. J\u00a0Am Coll Cardiol. 2020;76(16):1878\u2013901. https:\/\/doi.org\/10.1016\/j.jacc.2020.08.042.","journal-title":"J Am Coll Cardiol"},{"issue":"9","key":"2444_CR43","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1001\/jama.2022.1570","volume":"327","author":"JA Belperio","year":"2022","unstructured":"Belperio\u00a0JA, Shaikh\u00a0F, Abtin\u00a0FG, et\u00a0al. Diagnosis and treatment of pulmonary sarcoidosis: a\u00a0review. JAMA. 2022;327(9):856\u201367.","journal-title":"JAMA"},{"issue":"5","key":"2444_CR44","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1016\/S2213-2600(18)30064-X","volume":"6","author":"P Spagnolo","year":"2018","unstructured":"Spagnolo\u00a0P, Rossi\u00a0G, Trisolini\u00a0R, Sverzellati\u00a0N, Baughman\u00a0RP, Wells\u00a0AU. Pulmonary sarcoidosis. Lancet Respir Med. 2018;6(5):389\u2013402. https:\/\/doi.org\/10.1016\/S2213-2600(18)30064-X.","journal-title":"Lancet Respir Med"},{"issue":"5","key":"2444_CR45","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1055\/s-0040-1713615","volume":"41","author":"MP Huitema","year":"2020","unstructured":"Huitema\u00a0MP, Mathijssen\u00a0H, Mager\u00a0JJ, Snijder\u00a0RJ, Grutters\u00a0JC, Post\u00a0MC. Sarcoidosis-associated pulmonary hypertension. Semin Respir Crit Care Med. 2020;41(5):659\u201372. https:\/\/doi.org\/10.1055\/s-0040-1713615.","journal-title":"Semin Respir Crit Care Med"},{"key":"2444_CR46","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.rmed.2017.09.003","volume":"132","author":"NA Khan","year":"2017","unstructured":"Khan\u00a0NA, Donatelli\u00a0CV, Tonelli\u00a0AR, et\u00a0al. Toxicity risk from glucocorticoids in sarcoidosis patients. Respir Med. 2017;132:9\u201314. https:\/\/doi.org\/10.1016\/j.rmed.2017.09.003.","journal-title":"Respir Med"},{"key":"2444_CR47","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00198-2023","author":"S Dhooria","year":"2023","unstructured":"Dhooria\u00a0S, Sehgal\u00a0IS, Agarwal\u00a0R, et\u00a0al. High-dose (40\u202fmg) versus low-dose (20\u202fmg) prednisolone for treating sarcoidosis: a\u00a0randomised trial (SARCORT trial). Eur Respir\u00a0J. 2023; https:\/\/doi.org\/10.1183\/13993003.00198-2023.","journal-title":"Eur Respir J"},{"key":"2444_CR48","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0146-2019","author":"FF Rahaghi","year":"2020","unstructured":"Rahaghi\u00a0FF, Baughman\u00a0RP, Saketkoo\u00a0LA, et\u00a0al. Delphi consensus recommendations for a\u00a0treatment algorithm in pulmonary sarcoidosis. Eur Respir Rev. 2020; https:\/\/doi.org\/10.1183\/16000617.0146-2019.","journal-title":"Eur Respir Rev"},{"issue":"12","key":"2444_CR49","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1002\/art.42646","volume":"75","author":"MB Humphrey","year":"2023","unstructured":"Humphrey\u00a0MB, Russell\u00a0L, Danila\u00a0MI, et\u00a0al. 2022 American college of rheumatology guideline for the prevention and treatment of glucocorticoid-induced osteoporosis. Arthritis Rheumatol. 2023;75(12):2088\u2013102. https:\/\/doi.org\/10.1002\/art.42646.","journal-title":"Arthritis Rheumatol"},{"issue":"3","key":"2444_CR50","doi-asserted-by":"publisher","first-page":"e2020001","DOI":"10.36141\/svdld.v37i3.9362","volume":"37","author":"RP Baughman","year":"2020","unstructured":"Baughman\u00a0RP, Cremers\u00a0JP, Harmon\u00a0M, Lower\u00a0EE, Drent\u00a0M. Methotrexate in sarcoidosis: hematologic and hepatic toxicity encountered in a\u00a0 large cohort over a\u00a0six year period. Sarcoidosis. 2020;37(3):e2020001. https:\/\/doi.org\/10.36141\/svdld.v37i3.9362.","journal-title":"Sarcoidosis"},{"issue":"3","key":"2444_CR51","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1080\/17476348.2020.1707672","volume":"14","author":"A Pande","year":"2020","unstructured":"Pande\u00a0A, Culver\u00a0DA. Knowing when to use steroids, immunosuppressants or biologics for the treatment of sarcoidosis. Expert Rev Respir Med. 2020;14(3):285\u201398. https:\/\/doi.org\/10.1080\/17476348.2020.1707672.","journal-title":"Expert Rev Respir Med"},{"issue":"7","key":"2444_CR52","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1164\/rccm.200603-402OC","volume":"174","author":"RP Baughman","year":"2006","unstructured":"Baughman\u00a0RP, Drent\u00a0M, Kavuru\u00a0M, et\u00a0al. Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement. Am J Respir Crit Care Med. 2006;174(7):795\u2013802. https:\/\/doi.org\/10.1164\/rccm.200603-402OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2444_CR53","first-page":"46","volume":"31","author":"NJ Sweiss","year":"2014","unstructured":"Sweiss\u00a0NJ, Noth\u00a0I, Mirsaeidi\u00a0M, et\u00a0al. Efficacy results of a\u00a052-week trial of adalimumab in the treatment of refractory sarcoidosis. Sarcoidosis. 2014;31(1):46\u201354.","journal-title":"Sarcoidosis"},{"issue":"18","key":"2444_CR54","doi-asserted-by":"publisher","first-page":"1718","DOI":"10.1056\/NEJMoa1908681","volume":"381","author":"KR Flaherty","year":"2019","unstructured":"Flaherty\u00a0KR, Wells\u00a0AU, Cottin\u00a0V, et\u00a0al. Nintedanib in progressive fibrosing interstitial lung diseases. N\u00a0Engl J Med. 2019;381(18):1718\u201327. https:\/\/doi.org\/10.1056\/NEJMoa1908681.","journal-title":"N Engl J Med"},{"issue":"9","key":"2444_CR55","doi-asserted-by":"publisher","first-page":"e18","DOI":"10.1164\/rccm.202202-0399ST","volume":"205","author":"G Raghu","year":"2022","unstructured":"Raghu\u00a0G, Remy-Jardin\u00a0M, Richeldi\u00a0L, et\u00a0al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS\/ERS\/JRS\/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2022;205(9):e18\u2013e47. https:\/\/doi.org\/10.1164\/rccm.202202-0399ST.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2444_CR56","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1038\/s41467-022-30615-x","volume":"13","author":"W Damsky","year":"2022","unstructured":"Damsky\u00a0W, Wang\u00a0A, Kim\u00a0DJ, et\u00a0al. Inhibition of type\u00a01 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosis. Nat Commun. 2022;13(1):3140. https:\/\/doi.org\/10.1038\/s41467-022-30615-x.","journal-title":"Nat Commun"},{"issue":"5","key":"2444_CR57","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.1016\/j.jaci.2020.10.012","volume":"147","author":"A Wang","year":"2021","unstructured":"Wang\u00a0A, Rahman\u00a0N\u2011T, McGeary\u00a0MK, et\u00a0al. Treatment of granuloma annulare and suppression of proinflammatory cytokine activity with tofacitinib. J\u00a0Allergy Clin Immunol. 2021;147(5):1795\u2013809. https:\/\/doi.org\/10.1016\/j.jaci.2020.10.012.","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"2444_CR58","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1002\/acr2.11112","volume":"2","author":"W Damsky","year":"2020","unstructured":"Damsky\u00a0W, Young\u00a0BD, Sloan\u00a0B, Miller\u00a0EJ, Obando\u00a0JA, King\u00a0B. Treatment of multiorgan sarcoidosis with tofacitinib. ACR Open Rheumatol. 2020;2(2):106\u20139. https:\/\/doi.org\/10.1002\/acr2.11112.","journal-title":"ACR Open Rheumatol"},{"issue":"8","key":"2444_CR59","doi-asserted-by":"publisher","first-page":"654","DOI":"10.1161\/CIRCRESAHA.121.320449","volume":"131","author":"J Liu","year":"2022","unstructured":"Liu\u00a0J, Ma\u00a0P, Lai\u00a0L, et\u00a0al. Transcriptional and immune landscape of cardiac sarcoidosis. Circ Res. 2022;131(8):654\u201369. https:\/\/doi.org\/10.1161\/CIRCRESAHA.121.320449.","journal-title":"Circ Res"},{"key":"2444_CR60","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.202307-1273OC","author":"CX Lim","year":"2024","unstructured":"Lim\u00a0CX, Redl\u00a0A, Kleissl\u00a0L, et\u00a0al. Aberrant lipid metabolism in macrophages is associated with granuloma formation in sarcoidosis. Am J Respir Crit Care Med. 2024; https:\/\/doi.org\/10.1164\/rccm.202307-1273OC.","journal-title":"Am J Respir Crit Care Med"},{"issue":"2","key":"2444_CR61","doi-asserted-by":"publisher","first-page":"e81","DOI":"10.1016\/S2665-9913(23)00302-8","volume":"6","author":"A Redl","year":"2024","unstructured":"Redl\u00a0A, Doberer\u00a0K, Unterluggauer\u00a0L, et\u00a0al. Efficacy and safety of mTOR inhibition in cutaneous sarcoidosis: a\u00a0single-centre trial. Lancet Rheumatol. 2024;6(2):e81\u2013e91. https:\/\/doi.org\/10.1016\/S2665-9913(23)00302-8.","journal-title":"Lancet Rheumatol"},{"issue":"9","key":"2444_CR62","doi-asserted-by":"publisher","first-page":"e119","DOI":"10.1164\/rccm.202004-0914IM","volume":"202","author":"N Gupta","year":"2020","unstructured":"Gupta\u00a0N, Bleesing\u00a0JH, McCormack\u00a0FX. Successful response to treatment with sirolimus in pulmonary sarcoidosis. Am J Respir Crit Care Med. 2020;202(9):e119\u2013e20. https:\/\/doi.org\/10.1164\/rccm.202004-0914IM.","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"2444_CR63","doi-asserted-by":"publisher","first-page":"50","DOI":"10.2214\/AJR.19.21436","volume":"214","author":"GM Lee","year":"2020","unstructured":"Lee\u00a0GM, Pope\u00a0K, Meek\u00a0L, Chung\u00a0JH, Hobbs\u00a0SB, Walker\u00a0CM. Sarcoidosis: a\u00a0diagnosis of exclusion. AJR Am J Roentgenol. 2020;214(1):50\u20138. https:\/\/doi.org\/10.2214\/AJR.19.21436.","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"2444_CR64","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.rmed.2010.09.007","volume":"105","author":"F Kollert","year":"2011","unstructured":"Kollert\u00a0F, Geck\u00a0B, Suchy\u00a0R, et\u00a0al. The impact of gas exchange measurement during exercise in pulmonary sarcoidosis. Respir Med. 2011;105(1):122\u20139. https:\/\/doi.org\/10.1016\/j.rmed.2010.09.007.","journal-title":"Respir Med"},{"issue":"6","key":"2444_CR65","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1684\/ejd.2015.2666","volume":"25","author":"TC Esteves","year":"2015","unstructured":"Esteves\u00a0TC, Aparicio\u00a0G, Ferrer\u00a0B, Garcia-Patos\u00a0V. Prognostic value of skin lesions in sarcoidosis: clinical and histopathological clues. Eur J Dermatol. 2015;25(6):556\u201362. https:\/\/doi.org\/10.1684\/ejd.2015.2666.","journal-title":"Eur J Dermatol"},{"issue":"5","key":"2444_CR66","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1055\/s-0040-1713130","volume":"41","author":"A Caplan","year":"2020","unstructured":"Caplan\u00a0A, Rosenbach\u00a0M, Imadojemu\u00a0S. Cutaneous sarcoidosis. Semin Respir Crit Care Med. 2020;41(5):689\u201399. https:\/\/doi.org\/10.1055\/s-0040-1713130.","journal-title":"Semin Respir Crit Care Med"},{"issue":"5","key":"2444_CR67","doi-asserted-by":"publisher","first-page":"699.e1","DOI":"10.1016\/j.jaad.2011.11.965","volume":"66","author":"A Haimovic","year":"2012","unstructured":"Haimovic\u00a0A, Sanchez\u00a0M, Judson\u00a0MA, Prystowsky\u00a0S. Sarcoidosis: a\u00a0comprehensive review and update for the dermatologist: part I. Cutaneous disease. J\u00a0Am Acad Dermatol. 2012;66(5):699.e1\u2013699.18. https:\/\/doi.org\/10.1016\/j.jaad.2011.11.965. quiz 717\u2013718.","journal-title":"J Am Acad Dermatol"},{"issue":"7","key":"2444_CR68","doi-asserted-by":"publisher","first-page":"526","DOI":"10.1007\/s00105-017-4005-5","volume":"68","author":"T Giner","year":"2017","unstructured":"Giner\u00a0T, Benoit\u00a0S, Kneitz\u00a0H, Goebeler\u00a0M. Sarcoidosis : dermatological view of a\u00a0rare multisystem disease. Hautarzt. 2017;68(7):526\u201335. https:\/\/doi.org\/10.1007\/s00105-017-4005-5.","journal-title":"Hautarzt"},{"issue":"4","key":"2444_CR69","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1055\/s-0030-1262214","volume":"31","author":"NJ Sweiss","year":"2010","unstructured":"Sweiss\u00a0NJ, Patterson\u00a0K, Sawaqed\u00a0R, et\u00a0al. Rheumatologic manifestations of sarcoidosis. Semin Respir Crit Care Med. 2010;31(4):463\u201373. https:\/\/doi.org\/10.1055\/s-0030-1262214.","journal-title":"Semin Respir Crit Care Med"},{"issue":"5","key":"2444_CR70","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1093\/rheumatology\/kex317","volume":"57","author":"K Bechman","year":"2018","unstructured":"Bechman\u00a0K, Christidis\u00a0D, Walsh\u00a0S, Birring\u00a0SS, Galloway\u00a0J. A\u00a0review of the musculoskeletal manifestations of sarcoidosis. Rheumatology. 2018;57(5):777\u201383. https:\/\/doi.org\/10.1093\/rheumatology\/kex317.","journal-title":"Rheumatology"},{"issue":"5","key":"2444_CR71","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1177\/1759720X15591310","volume":"7","author":"S Kobak","year":"2015","unstructured":"Kobak\u00a0S. Sarcoidosis: a\u00a0rheumatologist\u2019s perspective. Ther Adv Musculoskelet Dis. 2015;7(5):196\u2013205. https:\/\/doi.org\/10.1177\/1759720X15591310.","journal-title":"Ther Adv Musculoskelet Dis"},{"issue":"3","key":"2444_CR72","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1002\/acr.24496","volume":"74","author":"N Hammam","year":"2022","unstructured":"Hammam\u00a0N, Evans\u00a0M, Morgan\u00a0E, et\u00a0al. Treatment of sarcoidosis in US rheumatology practices: data from the American college of rheumatology\u2019s rheumatology Informatics system for effectiveness (RISE) registry. Arthritis Care Res. 2022;74(3):371\u20136. https:\/\/doi.org\/10.1002\/acr.24496.","journal-title":"Arthritis Care Res"},{"issue":"6","key":"2444_CR73","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1111\/j.0954-6820.1953.tb07039.x","volume":"145","author":"S Lofgren","year":"1953","unstructured":"Lofgren\u00a0S. Primary pulmonary sarcoidosis. I. Early signs and symptoms. Acta Med Scand. 1953;145(6):424\u201331.","journal-title":"Acta Med Scand"},{"issue":"6","key":"2444_CR74","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1136\/ard.61.6.499","volume":"61","author":"H Visser","year":"2002","unstructured":"Visser\u00a0H, Vos\u00a0K, Zanelli\u00a0E, et\u00a0al. Sarcoid arthritis: clinical characteristics, diagnostic aspects, and risk factors. Ann Rheum Dis. 2002;61(6):499\u2013504. https:\/\/doi.org\/10.1136\/ard.61.6.499.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2444_CR75","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1093\/rheumatology\/34.1.45","volume":"34","author":"A Glenn\u00e5s","year":"1995","unstructured":"Glenn\u00e5s\u00a0A, Kvien\u00a0TK, Melby\u00a0K, et\u00a0al. Acute sarcoid arthritis: occurrence, seasonal onset, clinical features and outcome. Br J Rheumatol. 1995;34(1):45\u201350. https:\/\/doi.org\/10.1093\/rheumatology\/34.1.45.","journal-title":"Br J Rheumatol"},{"issue":"3","key":"2444_CR76","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/s0002-9343(99)00223-5","volume":"107","author":"J Ma\u00f1\u00e1","year":"1999","unstructured":"Ma\u00f1\u00e1\u00a0J, G\u00f3mez-Vaquero\u00a0C, Montero\u00a0A, et\u00a0al. L\u00f6fgren\u2019s syndrome revisited: a\u00a0study of 186 patients. Am J Med. 1999;107(3):240\u20135. https:\/\/doi.org\/10.1016\/s0002-9343(99)00223-5.","journal-title":"Am J Med"},{"issue":"1","key":"2444_CR77","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1097\/00002281-200401000-00010","volume":"16","author":"A Abril","year":"2004","unstructured":"Abril\u00a0A, Cohen\u00a0MD. Rheumatologic manifestations of sarcoidosis. Curr Opin Rheumatol. 2004;16(1):51\u20135. https:\/\/doi.org\/10.1097\/00002281-200401000-00010.","journal-title":"Curr Opin Rheumatol"},{"issue":"7","key":"2444_CR78","doi-asserted-by":"publisher","first-page":"e42","DOI":"10.2106\/JBJS.K.00062","volume":"94","author":"B Boyaci","year":"2012","unstructured":"Boyaci\u00a0B, Hornicek\u00a0F, Rosenthal\u00a0D, et\u00a0al. Sarcoidosis of the spine: a\u00a0report of five cases and a\u00a0review of the literature. J\u00a0Bone Joint Surg Am. 2012;94(7):e42. https:\/\/doi.org\/10.2106\/JBJS.K.00062.","journal-title":"J Bone Joint Surg Am"},{"key":"2444_CR79","doi-asserted-by":"publisher","first-page":"289454","DOI":"10.1155\/2014\/289454","volume":"2014","author":"S Kobak","year":"2014","unstructured":"Kobak\u00a0S, Sever\u00a0F, Ince\u00a0O, Orman\u00a0M. The prevalence of sacroiliitis and spondyloarthritis in patients with sarcoidosis. Int J Rheumatol. 2014;2014:289454. https:\/\/doi.org\/10.1155\/2014\/289454.","journal-title":"Int J Rheumatol"},{"issue":"6","key":"2444_CR80","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1016\/j.berh.2003.09.005","volume":"17","author":"H Awada","year":"2003","unstructured":"Awada\u00a0H, Abi-Karam\u00a0G, Fayad\u00a0F. Musculoskeletal and other extrapulmonary disorders in sarcoidosis. Best Pract Res Clin Rheumatol. 2003;17(6):971\u201387. https:\/\/doi.org\/10.1016\/j.berh.2003.09.005.","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"6","key":"2444_CR81","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1136\/ard.42.6.634","volume":"42","author":"P Pitt","year":"1983","unstructured":"Pitt\u00a0P, Hamilton\u00a0EB, Innes\u00a0EH, Morley\u00a0KD, Monk\u00a0BE, Hughes\u00a0GR. Sarcoid dactylitis. Ann Rheum Dis. 1983;42(6):634\u20139. https:\/\/doi.org\/10.1136\/ard.42.6.634.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"2444_CR82","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/j.diii.2014.11.038","volume":"97","author":"S Aptel","year":"2016","unstructured":"Aptel\u00a0S, Lecocq-Teixeira\u00a0S, Olivier\u00a0P, Regent\u00a0D, Teixeira\u00a0PG, Blum\u00a0A. Multimodality evaluation of musculoskeletal sarcoidosis: Imaging findings and literature review. Diagn Interv Imaging. 2016;97(1):5\u201318. https:\/\/doi.org\/10.1016\/j.diii.2014.11.038.","journal-title":"Diagn Interv Imaging"},{"issue":"3","key":"2444_CR83","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1001\/archneur.1969.00480150025002","volume":"21","author":"A Silverstein","year":"1969","unstructured":"Silverstein\u00a0A, Siltzbach\u00a0LE. Muscle involvement in sarcoidosis. Asymptomatic, myositis, and myopathy. Arch Neurol. 1969;21(3):235\u201341. https:\/\/doi.org\/10.1001\/archneur.1969.00480150025002.","journal-title":"Arch Neurol"},{"issue":"7","key":"2444_CR84","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1016\/j.nmd.2022.05.012","volume":"32","author":"L Ten Dam","year":"2022","unstructured":"Ten Dam\u00a0L, Raaphorst\u00a0J, van der Kooi\u00a0AJ, et\u00a0al. Clinical characteristics and outcome in muscular sarcoidosis: a\u00a0retrospective cohort study and literature review. Neuromuscul Disord. 2022;32(7):557\u201363. https:\/\/doi.org\/10.1016\/j.nmd.2022.05.012.","journal-title":"Neuromuscul. Disord."},{"issue":"3","key":"2444_CR85","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1183\/09031936.00117710","volume":"38","author":"RGJ Marcellis","year":"2011","unstructured":"Marcellis\u00a0RGJ, Lenssen\u00a0AF, Elfferich\u00a0MDP, et\u00a0al. Exercise capacity, muscle strength and fatigue in sarcoidosis. Eur Respir\u00a0J. 2011;38(3):628\u201334.","journal-title":"Eur Respir J"},{"issue":"1","key":"2444_CR86","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1016\/j.ccm.2023.08.003","volume":"45","author":"JT Rosenbaum","year":"2024","unstructured":"Rosenbaum\u00a0JT, Pasadhika\u00a0S. Ocular sarcoidosis. Clin Chest Med. 2024;45(1):59\u201370. https:\/\/doi.org\/10.1016\/j.ccm.2023.08.003.","journal-title":"Clin Chest Med"},{"key":"2444_CR87","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12093194","author":"S Giorgiutti","year":"2023","unstructured":"Giorgiutti\u00a0S, Jacquot\u00a0R, El Jammal\u00a0T, et\u00a0al. Sarcoidosis-related uveitis: a\u00a0review. J\u00a0Clin Med. 2023; https:\/\/doi.org\/10.3390\/jcm12093194.","journal-title":"J Clin Med"},{"issue":"10","key":"2444_CR88","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.1136\/bjophthalmol-2018-313356","volume":"103","author":"M Mochizuki","year":"2019","unstructured":"Mochizuki\u00a0M, Smith\u00a0JR, Takase\u00a0H, Kaburaki\u00a0T, Acharya\u00a0NR, Rao\u00a0NA. Revised criteria of international workshop on ocular sarcoidosis (IWOS) for the diagnosis of ocular sarcoidosis. Br J Ophthalmol. 2019;103(10):1418\u201322. https:\/\/doi.org\/10.1136\/bjophthalmol-2018-313356.","journal-title":"Br J Ophthalmol"},{"issue":"5","key":"2444_CR89","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1016\/j.ophtha.2017.11.017","volume":"125","author":"AD Dick","year":"2018","unstructured":"Dick\u00a0AD, Rosenbaum\u00a0JT, Al-Dhibi\u00a0HA, et\u00a0al. Guidance on noncorticosteroid systemic immunomodulatory therapy in noninfectious uveitis: fundamentals of care for UveitiS (FOCUS) initiative. Ophthalmology. 2018;125(5):757\u201373. https:\/\/doi.org\/10.1016\/j.ophtha.2017.11.017.","journal-title":"Ophthalmology"},{"issue":"38","key":"2444_CR90","doi-asserted-by":"publisher","first-page":"3618","DOI":"10.1093\/eurheartj\/ehac237","volume":"43","author":"M Humbert","year":"2022","unstructured":"Humbert\u00a0M, Kovacs\u00a0G, Hoeper\u00a0MM, et\u00a0al. 2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Heart\u00a0J. 2022;43(38):3618\u2013731. https:\/\/doi.org\/10.1093\/eurheartj\/ehac237.","journal-title":"Eur Heart J"},{"key":"2444_CR91","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00879-2022","author":"M Humbert","year":"2023","unstructured":"Humbert\u00a0M, Kovacs\u00a0G, Hoeper\u00a0MM, et\u00a0al. 2022 ESC\/ERS guidelines for the diagnosis and treatment of pulmonary hypertension. Eur Respir\u00a0J. 2023; https:\/\/doi.org\/10.1183\/13993003.00879-2022.","journal-title":"Eur Respir J"},{"key":"2444_CR92","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0165-2021","author":"L Savale","year":"2022","unstructured":"Savale\u00a0L, Huitema\u00a0M, Shlobin\u00a0O, et\u00a0al. WASOG statement on the diagnosis and management of sarcoidosis-associated pulmonary hypertension. Eur Respir Rev. 2022; https:\/\/doi.org\/10.1183\/16000617.0165-2021.","journal-title":"Eur Respir Rev"},{"key":"2444_CR93","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00465-2017","author":"A Boucly","year":"2017","unstructured":"Boucly\u00a0A, Cottin\u00a0V, Nunes\u00a0H, et\u00a0al. Management and long-term outcomes of sarcoidosis-associated pulmonary hypertension. Eur Respir\u00a0J. 2017; https:\/\/doi.org\/10.1183\/13993003.00465-2017.","journal-title":"Eur Respir J"},{"issue":"5","key":"2444_CR94","doi-asserted-by":"publisher","first-page":"582","DOI":"10.1097\/MCP.0000000000000701","volume":"26","author":"D Bandyopadhyay","year":"2020","unstructured":"Bandyopadhyay\u00a0D, Humbert\u00a0M. An update on sarcoidosis-associated pulmonary hypertension. Curr Opin Pulm Med. 2020;26(5):582\u201390. https:\/\/doi.org\/10.1097\/MCP.0000000000000701.","journal-title":"Curr Opin Pulm Med"},{"issue":"4","key":"2444_CR95","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1378\/chest.13-1766","volume":"145","author":"RP Baughman","year":"2014","unstructured":"Baughman\u00a0RP, Culver\u00a0DA, Cordova\u00a0FC, et\u00a0al. Bosentan for sarcoidosis-associated pulmonary hypertension: a\u00a0double-blind placebo controlled randomized trial. Chest. 2014;145(4):810\u20137. https:\/\/doi.org\/10.1378\/chest.13-1766.","journal-title":"Chest"},{"issue":"2","key":"2444_CR96","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1016\/j.chest.2021.07.2162","volume":"161","author":"RP Baughman","year":"2022","unstructured":"Baughman\u00a0RP, Shlobin\u00a0OA, Gupta\u00a0R, et\u00a0al. Riociguat for sarcoidosis-associated pulmonary hypertension: results of a\u00a01-year double-blind, placebo-controlled trial. Chest. 2022;161(2):448\u201357. https:\/\/doi.org\/10.1016\/j.chest.2021.07.2162.","journal-title":"Chest"},{"key":"2444_CR97","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.03358-2020","author":"J Le Pavec","year":"2021","unstructured":"Le Pavec\u00a0J, Valeyre\u00a0D, Gazengel\u00a0P, et\u00a0al. Lung transplantation for sarcoidosis: outcome and prognostic factors. Eur Respir\u00a0J. 2021; https:\/\/doi.org\/10.1183\/13993003.03358-2020.","journal-title":"Eur Respir J"},{"key":"2444_CR98","doi-asserted-by":"publisher","unstructured":". A joint procedural position statement on imaging in cardiac sarcoidosis: from the cardiovascular and inflammation & infection committees of the European association of nuclear medicine, the European association of cardiovascular imaging, and the American. Eur Heart J Cardiovasc Imaging. 2017;18(10):1073\u201389. https:\/\/doi.org\/10.1093\/ehjci\/jex146.","DOI":"10.1093\/ehjci\/jex146"},{"issue":"4","key":"2444_CR99","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1016\/j.jacc.2016.03.605","volume":"68","author":"DH Birnie","year":"2016","unstructured":"Birnie\u00a0DH, Nery\u00a0PB, Ha\u00a0AC, Beanlands\u00a0RSB. Cardiac sarcoidosis. J\u00a0Am Coll Cardiol. 2016;68(4):411\u201321. https:\/\/doi.org\/10.1016\/j.jacc.2016.03.605.","journal-title":"J. Am. Coll. Cardiol."},{"issue":"6","key":"2444_CR100","doi-asserted-by":"publisher","first-page":"854","DOI":"10.1002\/ejhf.2190","volume":"23","author":"PM Seferovi\u0107","year":"2021","unstructured":"Seferovi\u0107\u00a0PM, Tsutsui\u00a0H, McNamara\u00a0DM, et\u00a0al. Heart failure association of the ESC, heart failure society of america and Japanese heart failure society position statement on endomyocardial biopsy. Eur J Heart Fail. 2021;23(6):854\u201371. https:\/\/doi.org\/10.1002\/ejhf.2190.","journal-title":"Eur J Heart Fail"},{"issue":"5","key":"2444_CR101","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1016\/j.jchf.2014.03.015","volume":"2","author":"JJ Liang","year":"2014","unstructured":"Liang\u00a0JJ, Hebl\u00a0VB, DeSimone\u00a0CV, et\u00a0al. Electrogram guidance: a\u00a0method to increase the precision and diagnostic yield of endomyocardial biopsy for suspected cardiac sarcoidosis and myocarditis. JACC Heart Fail. 2014;2(5):466\u201373. https:\/\/doi.org\/10.1016\/j.jchf.2014.03.015.","journal-title":"JACC Heart Fail"},{"issue":"1","key":"2444_CR102","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1007\/s10840-018-0410-7","volume":"53","author":"VR Vaidya","year":"2018","unstructured":"Vaidya\u00a0VR, Abudan\u00a0AA, Vasudevan\u00a0K, et\u00a0al. The efficacy and safety of electroanatomic mapping-guided endomyocardial biopsy: a\u00a0systematic review. J\u00a0Interv Card Electrophysiol. 2018;53(1):63\u201371. https:\/\/doi.org\/10.1007\/s10840-018-0410-7.","journal-title":"J Interv Card Electrophysiol"},{"issue":"37","key":"2444_CR103","doi-asserted-by":"publisher","first-page":"3503","DOI":"10.1093\/eurheartj\/ehad194","volume":"44","author":"E Arbelo","year":"2023","unstructured":"Arbelo\u00a0E, Protonotarios\u00a0A, Gimeno\u00a0JR, et\u00a0al. 2023 ESC guidelines for the management of cardiomyopathies. Eur Heart\u00a0J. 2023;44(37):3503\u2013626. https:\/\/doi.org\/10.1093\/eurheartj\/ehad194.","journal-title":"Eur Heart J"},{"issue":"7","key":"2444_CR104","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1016\/j.hrthm.2014.03.043","volume":"11","author":"DH Birnie","year":"2014","unstructured":"Birnie\u00a0DH, Sauer\u00a0WH, Bogun\u00a0F, et\u00a0al. HRS expert consensus statement on the diagnosis and management of arrhythmias associated with cardiac sarcoidosis. Heart Rhythm. 2014;11(7):1305\u201323. https:\/\/doi.org\/10.1016\/j.hrthm.2014.03.043.","journal-title":"Heart Rhythm"},{"issue":"12","key":"2444_CR105","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1093\/ehjci\/jeaa299","volume":"21","author":"RHJA Slart","year":"2020","unstructured":"Slart\u00a0RHJA, Glaudemans\u00a0AWJM, Gheysens\u00a0O, et\u00a0al. Procedural recommendations of cardiac PET\/CT imaging: standardization in inflammatory-, infective-, infiltrative-, and innervation- (4Is) related cardiovascular diseases: a\u00a0joint collaboration of the EACVI and the EANM: summary. Eur Heart J Cardiovasc Imaging. 2020;21(12):1320\u201330. https:\/\/doi.org\/10.1093\/ehjci\/jeaa299.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"2444_CR106","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1378\/chest.11-0263","volume":"141","author":"NY Hamzeh","year":"2012","unstructured":"Hamzeh\u00a0NY, Wamboldt\u00a0FS, Weinberger\u00a0HD. Management of cardiac sarcoidosis in the United States: a\u00a0Delphi study. Chest. 2012;141(1):154\u201362. https:\/\/doi.org\/10.1378\/chest.11-0263.","journal-title":"Chest"},{"issue":"3","key":"2444_CR107","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1055\/a-2259-1046","volume":"78","author":"D Skowasch","year":"2024","unstructured":"Skowasch\u00a0D, Bonella\u00a0F, Buschulte\u00a0K, et\u00a0al. Therapeutic pathways in sarcoidosisA position paper of the German society of respiratory medicine (DGP). Pneumologie. 2024;78(3):151\u201366. https:\/\/doi.org\/10.1055\/a-2259-1046.","journal-title":"Pneumologie"},{"key":"2444_CR108","doi-asserted-by":"publisher","first-page":"107121","DOI":"10.1016\/j.rmed.2023.107121","volume":"209","author":"R Bergner","year":"2023","unstructured":"Bergner\u00a0R, Weiner\u00a0SM, Kehl\u00a0G, et\u00a0al. Renal disease in sarcoidosis patients in a\u00a0German multicentric retrospective cohort study. Respir Med. 2023;209:107121. https:\/\/doi.org\/10.1016\/j.rmed.2023.107121.","journal-title":"Respir Med"},{"issue":"1","key":"2444_CR109","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.nephro.2021.08.001","volume":"18","author":"I Gorsane","year":"2022","unstructured":"Gorsane\u00a0I, Zammouri\u00a0A, Hajji\u00a0M, et\u00a0al. Renal involvement in sarcoidosis: prognostic and predictive factors. Nephrol Ther. 2022;18(1):52\u20138. https:\/\/doi.org\/10.1016\/j.nephro.2021.08.001.","journal-title":"Nephrol Ther"},{"issue":"1","key":"2444_CR110","doi-asserted-by":"publisher","first-page":"15","DOI":"10.2214\/ajr.182.1.1820015","volume":"182","author":"DM Warshauer","year":"2004","unstructured":"Warshauer\u00a0DM, Lee\u00a0JKT. Imaging manifestations of abdominal sarcoidosis. AJR Am J Roentgenol. 2004;182(1):15\u201328. https:\/\/doi.org\/10.2214\/ajr.182.1.1820015.","journal-title":"AJR Am J Roentgenol"},{"issue":"5","key":"2444_CR111","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1097\/MCP.0000000000000504","volume":"24","author":"R Bergner","year":"2018","unstructured":"Bergner\u00a0R, L\u00f6ffler\u00a0C. Renal sarcoidosis: approach to diagnosis and management. Curr Opin Pulm Med. 2018;24(5):513\u201320. https:\/\/doi.org\/10.1097\/MCP.0000000000000504.","journal-title":"Curr Opin Pulm Med"},{"issue":"4","key":"2444_CR112","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1093\/ndt\/gfac219","volume":"38","author":"S Mehta","year":"2023","unstructured":"Mehta\u00a0S, Lightle\u00a0A, Judson\u00a0MA. Renal sarcoidosis. Nephrol Dial Transplant. 2023;38(4):803\u201310. https:\/\/doi.org\/10.1093\/ndt\/gfac219.","journal-title":"Nephrol Dial Transplant"},{"issue":"2","key":"2444_CR113","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1097\/MD.0b013e31819de50f","volume":"88","author":"M Mah\u00e9vas","year":"2009","unstructured":"Mah\u00e9vas\u00a0M, Lescure\u00a0FX, Boffa\u00a0J\u2011J, et\u00a0al. Renal sarcoidosis: clinical, laboratory, and histologic presentation and outcome in 47\u00a0patients. Medicine. 2009;88(2):98\u2013106. https:\/\/doi.org\/10.1097\/MD.0b013e31819de50f.","journal-title":"Medicine"},{"issue":"10","key":"2444_CR114","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1093\/ndt\/gft442","volume":"29","author":"I Hilderson","year":"2014","unstructured":"Hilderson\u00a0I, Van Laecke\u00a0S, Wauters\u00a0A, Donck\u00a0J. Treatment of renal sarcoidosis: is there a\u00a0guideline? Overview of the different treatment options. Nephrol Dial Transplant. 2014;29(10):1841\u20137. https:\/\/doi.org\/10.1093\/ndt\/gft442.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"2444_CR115","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1186\/s12883-016-0741-x","volume":"16","author":"D Fritz","year":"2016","unstructured":"Fritz\u00a0D, van de Beek\u00a0D, Brouwer\u00a0MC. Clinical features, treatment and outcome in neurosarcoidosis: systematic review and meta-analysis. BMC Neurol. 2016;16(1):220. https:\/\/doi.org\/10.1186\/s12883-016-0741-x.","journal-title":"BMC Neurol"},{"key":"2444_CR116","doi-asserted-by":"publisher","DOI":"10.1212\/NXI.0000000000001084","author":"MJ Bradshaw","year":"2021","unstructured":"Bradshaw\u00a0MJ, Pawate\u00a0S, Koth\u00a0LL, Cho\u00a0TA, Gelfand\u00a0JM. Neurosarcoidosis: pathophysiology, diagnosis, and treatment. Neurol Neuroimmunol Neuroinflamm. 2021; https:\/\/doi.org\/10.1212\/NXI.0000000000001084.","journal-title":"Neurol Neuroimmunol Neuroinflamm"},{"issue":"7","key":"2444_CR117","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1093\/qjmed\/hcp042","volume":"102","author":"S Pawate","year":"2009","unstructured":"Pawate\u00a0S, Moses\u00a0H, Sriram\u00a0S. Presentations and outcomes of neurosarcoidosis: a\u00a0study of 54\u00a0cases. QJM. 2009;102(7):449\u201360. https:\/\/doi.org\/10.1093\/qjmed\/hcp042.","journal-title":"QJM"},{"issue":"5","key":"2444_CR118","first-page":"973","volume":"15","author":"FJ Lexa","year":"1994","unstructured":"Lexa\u00a0FJ, Grossman\u00a0RI. MR of sarcoidosis in the head and spine: spectrum of manifestations and radiographic response to steroid therapy. AJNR Am J Neuroradiol. 1994;15(5):973\u201382.","journal-title":"AJNR Am J Neuroradiol"},{"key":"2444_CR119","doi-asserted-by":"publisher","first-page":"1135392","DOI":"10.3389\/fneur.2023.1135392","volume":"14","author":"B Vlad","year":"2023","unstructured":"Vlad\u00a0B, Neidhart\u00a0S, Hilty\u00a0M, Ziegler\u00a0M, Jelcic\u00a0I. Differentiating neurosarcoidosis from multiple sclerosis using combined analysis of basic CSF parameters and MRZ reaction. Front Neurol. 2023;14:1135392. https:\/\/doi.org\/10.3389\/fneur.2023.1135392.","journal-title":"Front Neurol"},{"key":"2444_CR120","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s42466-020-00063-3","volume":"2","author":"T Schlereth","year":"2020","unstructured":"Schlereth\u00a0T. Guideline \u201cdiagnosis and non interventional therapy of neuropathic pain\u201d of the German Society of Neurology (deutsche Gesellschaft f\u00fcr Neurologie). Neurol Res Pract. 2020;2:16. https:\/\/doi.org\/10.1186\/s42466-020-00063-3.","journal-title":"Neurol Res Pract"},{"issue":"4","key":"2444_CR121","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1002\/cld.1055","volume":"17","author":"N Shah","year":"2021","unstructured":"Shah\u00a0N, Mitra\u00a0A. Gastrointestinal and hepatic sarcoidosis: a\u00a0review article. Clin Liver Dis. 2021;17(4):301\u20137. https:\/\/doi.org\/10.1002\/cld.1055.","journal-title":"Clin Liver Dis"},{"issue":"8","key":"2444_CR122","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.14309\/ajg.0000000000000171","volume":"114","author":"P Brito-Zer\u00f3n","year":"2019","unstructured":"Brito-Zer\u00f3n\u00a0P, Bari\u00a0K, Baughman\u00a0RP, Ramos-Casals\u00a0M. Sarcoidosis involving the gastrointestinal tract: diagnostic and therapeutic management. Am J Gastroenterol. 2019;114(8):1238\u201347. https:\/\/doi.org\/10.14309\/ajg.0000000000000171.","journal-title":"Am J Gastroenterol"},{"issue":"12","key":"2444_CR123","doi-asserted-by":"publisher","first-page":"3316","DOI":"10.1007\/s10620-006-9448-y","volume":"52","author":"B Vahid","year":"2007","unstructured":"Vahid\u00a0B, Spodik\u00a0M, Braun\u00a0KN, Ghazi\u00a0LJ, Esmaili\u00a0A. Sarcoidosis of gastrointestinal tract: a\u00a0rare disease. Dig Dis Sci. 2007;52(12):3316\u201320. https:\/\/doi.org\/10.1007\/s10620-006-9448-y.","journal-title":"Dig Dis Sci"},{"issue":"29","key":"2444_CR124","doi-asserted-by":"publisher","first-page":"e4279","DOI":"10.1097\/MD.0000000000004279","volume":"95","author":"E Ghrenassia","year":"2016","unstructured":"Ghrenassia\u00a0E, Mekinian\u00a0A, Chapelon-Albric\u00a0C, et\u00a0al. Digestive-tract sarcoidosis: French nationwide case-control study of 25\u00a0cases. Medicine. 2016;95(29):e4279. https:\/\/doi.org\/10.1097\/MD.0000000000004279.","journal-title":"Medicine"},{"issue":"1","key":"2444_CR125","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1055\/s-2007-970335","volume":"28","author":"MA Judson","year":"2007","unstructured":"Judson\u00a0MA. Extrapulmonary sarcoidosis. Semin Respir Crit Care Med. 2007;28(1):83\u2013101. https:\/\/doi.org\/10.1055\/s-2007-970335.","journal-title":"Semin Respir Crit Care Med"},{"key":"2444_CR126","doi-asserted-by":"publisher","unstructured":". EASL clinical practice guidelines: management of cholestatic liver diseases. j Hepatol. 2009;51(2):237\u201367. https:\/\/doi.org\/10.1016\/j.jhep.2009.04.009.","DOI":"10.1016\/j.jhep.2009.04.009"},{"issue":"3","key":"2444_CR127","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1097\/00004728-199705000-00006","volume":"21","author":"GC Scott","year":"1997","unstructured":"Scott\u00a0GC, Berman\u00a0JM, Higgins\u00a0JLJ. CT patterns of nodular hepatic and splenic sarcoidosis: a\u00a0review of the literature. J\u00a0Comput Assist Tomogr. 1997;21(3):369\u201372. https:\/\/doi.org\/10.1097\/00004728-199705000-00006.","journal-title":"J Comput Assist Tomogr"},{"issue":"2","key":"2444_CR128","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.path.2018.02.008","volume":"11","author":"E-YK Choi","year":"2018","unstructured":"Choi\u00a0E\u2011YK, Lamps\u00a0LW. Granulomas in the liver, with a\u00a0focus on infectious causes. Surg Pathol Clin. 2018;11(2):231\u201350. https:\/\/doi.org\/10.1016\/j.path.2018.02.008.","journal-title":"Surg Pathol Clin"},{"issue":"1","key":"2444_CR129","doi-asserted-by":"publisher","first-page":"196","DOI":"10.1007\/s10620-005-1300-2","volume":"50","author":"B Alenezi","year":"2005","unstructured":"Alenezi\u00a0B, Lamoureux\u00a0E, Alpert\u00a0L, Szilagyi\u00a0A. Effect of ursodeoxycholic acid on granulomatous liver disease due to sarcoidosis. Dig Dis Sci. 2005;50(1):196\u2013200. https:\/\/doi.org\/10.1007\/s10620-005-1300-2.","journal-title":"Dig Dis Sci"},{"issue":"8","key":"2444_CR130","first-page":"349","volume":"70","author":"GJ Bakker","year":"2012","unstructured":"Bakker\u00a0GJ, Haan\u00a0YCL, Maillette de Buy Wenniger\u00a0LJ, Beuers\u00a0U. Sarcoidosis of the liver: to treat or not to treat? Neth J Med. 2012;70(8):349\u201356.","journal-title":"Neth J Med"},{"issue":"5","key":"2444_CR131","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1097\/MCP.0b013e3283541626","volume":"18","author":"JP Cremers","year":"2012","unstructured":"Cremers\u00a0JP, Drent\u00a0M, Baughman\u00a0RP, Wijnen\u00a0PA, Koek\u00a0GH. Therapeutic approach of hepatic sarcoidosis. Curr Opin Pulm Med. 2012;18(5):472\u201382. https:\/\/doi.org\/10.1097\/MCP.0b013e3283541626.","journal-title":"Curr Opin Pulm Med"},{"issue":"10","key":"2444_CR132","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1080\/17476348.2016.1227244","volume":"10","author":"B Strookappe","year":"2016","unstructured":"Strookappe\u00a0B, Saketkoo\u00a0LA, Elfferich\u00a0M, et\u00a0al. Physical activity and training in sarcoidosis: review and experience-based recommendations. Expert Rev Respir Med. 2016;10(10):1057\u201368. https:\/\/doi.org\/10.1080\/17476348.2016.1227244.","journal-title":"Expert Rev Respir Med"},{"issue":"5","key":"2444_CR133","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1159\/000486964","volume":"95","author":"H Lingner","year":"2018","unstructured":"Lingner\u00a0H, Buhr-Schinner\u00a0H, Hummel\u00a0S, et\u00a0al. Short-term effects of a\u00a0multimodal 3\u2011week inpatient pulmonary rehabilitation programme for patients with sarcoidosis: the ProKaSaRe study. Respiration. 2018;95(5):343\u201353. https:\/\/doi.org\/10.1159\/000486964.","journal-title":"Respiration"},{"key":"2444_CR134","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.resmer.2019.10.003","volume":"77","author":"B Wallaert","year":"2020","unstructured":"Wallaert\u00a0B, Kyheng\u00a0M, Labreuche\u00a0J, Stelianides\u00a0S, Wemeau\u00a0L, Grosbois\u00a0JM. Long-term effects of pulmonary rehabilitation on daily life physical activity of patients with stage\u00a0IV sarcoidosis: a\u00a0randomized controlled trial. Respir Med Res. 2020;77:1\u20137. https:\/\/doi.org\/10.1016\/j.resmer.2019.10.003.","journal-title":"Respir Med Res"},{"issue":"4","key":"2444_CR135","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1016\/j.pulmoe.2022.09.004","volume":"29","author":"R Gloeckl","year":"2023","unstructured":"Gloeckl\u00a0R, Zwick\u00a0RH, F\u00fcrlinger\u00a0U, et\u00a0al. Prescribing and adjusting exercise training in chronic respiratory diseases\u2014expert-based practical recommendations. Pulmonology. 2023;29(4):306\u201314. https:\/\/doi.org\/10.1016\/j.pulmoe.2022.09.004.","journal-title":"Pulmonology"},{"key":"2444_CR136","doi-asserted-by":"publisher","first-page":"107433","DOI":"10.1016\/j.rmed.2023.107433","volume":"219","author":"B Luu","year":"2023","unstructured":"Luu\u00a0B, Gupta\u00a0A, Fabiano\u00a0N, et\u00a0al. Influence of pulmonary rehabilitation on symptoms of anxiety and depression in interstitial lung disease: a\u00a0systematic review of randomized controlled trials. Respir Med. 2023;219:107433. https:\/\/doi.org\/10.1016\/j.rmed.2023.107433.","journal-title":"Respir Med"},{"key":"2444_CR137","unstructured":"European Association of Patients Organizations of Sarcoidosis and other Granulomatous Disorders (EPOS). EURORDIS sarcoidosis patient journey. 2021. https:\/\/ern-lung.eu\/wp-content\/uploads\/2021\/01\/Sarc-PJ-Final.jpg.."},{"issue":"4","key":"2444_CR138","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.ccm.2015.08.013","volume":"36","author":"M Drent","year":"2015","unstructured":"Drent\u00a0M, Strookappe\u00a0B, Hoitsma\u00a0E, De Vries\u00a0J. Consequences of sarcoidosis. Clin Chest Med. 2015;36(4):727\u201337. https:\/\/doi.org\/10.1016\/j.ccm.2015.08.013.","journal-title":"Clin Chest Med"},{"issue":"2","key":"2444_CR139","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00408-019-00206-7","volume":"197","author":"M Voortman","year":"2019","unstructured":"Voortman\u00a0M, Hendriks\u00a0CMR, Elfferich\u00a0MDP, et\u00a0al. The burden of sarcoidosis symptoms from a\u00a0patient perspective. Lung. 2019;197(2):155\u201361.","journal-title":"Lung"},{"issue":"4","key":"2444_CR140","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1007\/s00408-019-00234-3","volume":"197","author":"CMR Hendriks","year":"2019","unstructured":"Hendriks\u00a0CMR, Saketkoo\u00a0LA, Elfferich\u00a0MDP, De Vries\u00a0J, Wijnen\u00a0PAHM, Drent\u00a0M. Sarcoidosis and work participation: the need to develop a\u00a0disease-specific core set for assessment of work ability. Lung. 2019;197(4):407\u201313. https:\/\/doi.org\/10.1007\/s00408-019-00234-3.","journal-title":"Lung"},{"key":"2444_CR141","unstructured":"European Lung Foundation. Sarcoidosis patient priorities. https:\/\/europeanlunginfo.org\/sarcoidosis\/library\/.."},{"key":"2444_CR142","doi-asserted-by":"publisher","DOI":"10.2307\/j.ctt9qh7zv.35","author":"J Hutchinson","year":"1877","unstructured":"Hutchinson\u00a0J. Anomalous diseases of skin and fingers. Illus Clin Surg. 1877; https:\/\/doi.org\/10.2307\/j.ctt9qh7zv.35.","journal-title":"Illus Clin Surg"},{"key":"2444_CR143","doi-asserted-by":"publisher","DOI":"10.1183\/16000617.0145-2019","author":"RP Baughman","year":"2020","unstructured":"Baughman\u00a0RP, Scholand\u00a0MB, Rahaghi\u00a0FF. Clinical phenotyping: role in treatment decisions in sarcoidosis. Eur Respir Rev. 2020; https:\/\/doi.org\/10.1183\/16000617.0145-2019.","journal-title":"Eur Respir Rev"}],"updated-by":[{"DOI":"10.1007\/s00508-024-02487-2","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2024,12,16]],"date-time":"2024-12-16T00:00:00Z","timestamp":1734307200000}}],"container-title":["Wiener klinische Wochenschrift"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-024-02444-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00508-024-02444-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00508-024-02444-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T19:04:18Z","timestamp":1734462258000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00508-024-02444-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":143,"journal-issue":{"issue":"S17","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["2444"],"URL":"https:\/\/doi.org\/10.1007\/s00508-024-02444-z","relation":{"correction":[{"id-type":"doi","id":"10.1007\/s00508-024-02487-2","asserted-by":"object"}]},"ISSN":["0043-5325","1613-7671"],"issn-type":[{"value":"0043-5325","type":"print"},{"value":"1613-7671","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"28 August 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2024","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 October 2024","order":3,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Update","order":4,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"In diesem Artikel wurde der Name von dem Autor M. Idzko f\u00e4lschlicherweise als M. Izdko angegeben.","order":5,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Weiterhin waren die Adressdaten bzw. die Daten zur institutionellen Zugeh\u00f6rigkeit f\u00fcr K. Kastrati falsch angegeben. Statt Universit\u00e4tsklinik f\u00fcr Innere Medizin II, Medizinische Universit\u00e4t Innsbruck, Innsbruck, \u00d6sterreich h\u00e4tte sie Universit\u00e4tsklinik f\u00fcr Innere Medizin III, Klinische Abteilung f\u00fcr Rheumatologie, Medizinische Universit\u00e4t Wien, Wien, \u00d6sterreich lauten sollen.","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Au\u00dferdem waren die Adressdaten f\u00fcr R.H. Zwick unvollst\u00e4ndig und h\u00e4tten lauten sollen Ambulante Rehabilitation, Ludwig Boltzmann Institute for Rehabilitation Research, Therme Wien Med, Wien, \u00d6sterreich.","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":8,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":9,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":10,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1007\/s00508-024-02487-2","URL":"https:\/\/doi.org\/10.1007\/s00508-024-02487-2","order":11,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"G.\u00a0Sterniste, K.\u00a0Hackner, F.\u00a0Moazedi-F\u00fcrst, M.\u00a0Grasl, M.\u00a0Idzko, G.\u00a0Shao, C.\u00a0Guttmann-Ducke, E.\u00a0Talaki\u0107, H.\u00a0Prosch, S.\u00a0Lohfink-Schumm, M.\u00a0Gabriel, C.\u00a0Lim, J.\u00a0Hochreiter, B.\u00a0Bucher, B.C.\u00a0B\u00f6ckle, H.P.\u00a0Kiener, C.\u00a0Duftner, K.\u00a0Kastrati, E.\u00a0Rath, M.\u00a0Funk, J.\u00a0L\u00f6ffler-Ragg, M.\u00a0Steinmaurer, G.\u00a0Kovacs, N.\u00a0Verheyen, H.\u00a0Flick, M.\u00a0Antlanger, G.\u00a0Traxler, E.\u00a0Tatscher, R.H.\u00a0Zwick und D.\u00a0Lang geben an, dass kein Interessenkonflikt besteht.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}